Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Gp, Ionis was formerly ISIS. They are our main competition. Their drug results do not validate our delivery system because they use a positive charged vehicle while we use a neutral charge. In the past the positively charged delivery system caused side effects.
The fact that their delivery system now has a favorable safety profile is NOT good new for us.

http://www.businesswire.com/news/home/20161107005392/en/Biogen-Ionis-Pharmaceuticals-Announce-SPINRAZA-nusinersen-Meets

The good news is that their results appear to validate that antisense works when delivered properly but we knew this already.

Too bad we were not the first company with a safe delivery system. I hope the two year delay in moving our drug forward does not lead to the Ionis delivery system becoming the industry standard.

As far as the stock price, they already have an antisense drug approved by the FDA and Big Pharma partners so they are WAY ahead of us! Do not expect a 3.8 billion dollar market cap for sometime based on our past performance.

http://www.ionispharma.com/pipeline/

This news actually disappoints me because I was betting Ionis would need our non-toxic delivery system for their anti-sense drugs which now appears to be less likely.